Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 January 2024 | Story Gerda-Marié van Rooyen | Photo Chris Nelson
Dr Maryam Amra Jordaan
Dr Maryam Amra Jordaan, co-founded SA Rebuilders.

Only 16% of plastic gets recycled in South Africa, despite technological advancements. While the Extended Producer Responsibility (EPR) Regulation of 2021 assigns post-consumer recycling responsibility to producers, substantial efforts are needed to develop effective waste management strategies, heighten public awareness, discover practical solutions, and hold plastic-producing companies accountable.

Prioritising environmental sustainability

Dr Maryam Amra Jordaan co-founded SA Rebuilders with her husband, Yasar Amra, in 2016. By combining 3D printing, chemistry, and plastic recycling, they tackle socio-economic issues while prioritising environmental sustainability. As the daughter of a miner from Kimberley, Dr Jordaan is committed to mitigating the negative effects that industries have on the health, environment, and social aspects of local communities. She was honoured with an Alumni Cum Laude Award from the University of the Free State (UFS) for her work in this regard.

Dr Jordaan’s academic journey at the UFS from 2001 to 2013 includes a BSc in Chemistry and Physiology, BSc Honours, MSc, and a PhD in Organic Chemistry. She dedicated five years to lecturing and research on the Qwaqwa Campus and four years at the Mangosuthu University of Technology (MUT). During this time, she authored 19 pharmaceutical and environmental chemistry research papers and won numerous national and international awards. She entered the UFS with dreams of assisting in some way and ended up helping to solve the Sustainable Development Goals (SDGs).

“Remarkable potential for rapid prototyping and supply chain resilience through digitisation exists, but the current energy crisis hampers the full realisation of 3D printing’s potential,” Dr Jordaan explains. Added to this, is the complex endeavour of becoming a 3D engineer. “Expertise in materials science and project management is equally essential. Creativity, quick learning, and meticulous attention to detail are all characteristics necessary to excel as a 3D engineer.”

Seeking out biodegradable product alternatives

Dr Jordaan stresses the need for effective waste management, awareness, practical solutions, and accountability for individuals and plastic-producing companies. Therefore, she promotes reusable and recyclable shopping bags, among others, and instils this behaviour in her children. The Amras actively seek out biodegradable product alternatives, as they are fully aware of the environmental impact of the manufacturing industry.

They incorporated this ideology in the manufacturing process of organic butter by transforming the plastic waste from this process into a 3D filament. This product is currently undergoing SABS testing, after which it will be available to the local market.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept